X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (113) 113
melanoma (96) 96
ipilimumab (88) 88
oncology (83) 83
immunotherapy (81) 81
melanoma - drug therapy (53) 53
cancer (52) 52
female (52) 52
male (51) 51
middle aged (46) 46
aged (44) 44
metastatic melanoma (43) 43
antibodies, monoclonal - therapeutic use (38) 38
care and treatment (37) 37
adult (36) 36
nivolumab (35) 35
survival (35) 35
metastasis (29) 29
aged, 80 and over (28) 28
patients (26) 26
abridged index medicus (25) 25
pembrolizumab (24) 24
melanoma - pathology (23) 23
skin neoplasms - drug therapy (23) 23
antibodies, monoclonal - adverse effects (22) 22
tumors (22) 22
immunotherapy - methods (21) 21
melanoma - immunology (21) 21
drug therapy (20) 20
immunology (20) 20
research (20) 20
lymphocytes (19) 19
programmed cell death 1 receptor - antagonists & inhibitors (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
ctla-4 (18) 18
retrospective studies (18) 18
chemotherapy (17) 17
ctla-4 antigen - antagonists & inhibitors (17) 17
ctla-4 blockade (17) 17
neoplasms - immunology (17) 17
animals (16) 16
lymphocytes t (16) 16
metastases (16) 16
prognosis (16) 16
safety (16) 16
therapy (16) 16
treatment outcome (16) 16
antineoplastic agents - adverse effects (15) 15
cancer therapies (15) 15
pd-1 (15) 15
programmed cell death 1 receptor - immunology (15) 15
skin neoplasms - pathology (15) 15
antineoplastic agents - therapeutic use (14) 14
biomarkers (14) 14
clinical trials (14) 14
cytotoxicity (14) 14
immune checkpoint (14) 14
medicine, general & internal (14) 14
medicine, research & experimental (14) 14
t cells (14) 14
antibodies, monoclonal - administration & dosage (13) 13
ctla-4 antigen - immunology (13) 13
mutation (13) 13
open-label (13) 13
anti-pd-1 (12) 12
dosage and administration (12) 12
medical research (12) 12
melanoma - mortality (12) 12
melanoma - therapy (12) 12
neoplasms - therapy (12) 12
usage (12) 12
cell biology (11) 11
health aspects (11) 11
melanoma - secondary (11) 11
pd-1 protein (11) 11
radiotherapy (11) 11
vemurafenib (11) 11
antibodies (10) 10
apoptosis (10) 10
ctla-4 protein (10) 10
medicine (10) 10
neoplasm staging (10) 10
neoplasms - drug therapy (10) 10
respiratory system (10) 10
studies (10) 10
untreated melanoma (10) 10
young adult (10) 10
antibody (9) 9
cell lung-cancer (9) 9
combined modality therapy (9) 9
cytotoxic t-lymphocyte antigen 4 (9) 9
diagnosis (9) 9
immune system (9) 9
antibodies, monoclonal, humanized - therapeutic use (8) 8
antigens (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
antitumor immunity (8) 8
b7-h1 antigen - antagonists & inhibitors (8) 8
disease-free survival (8) 8
immune response (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 14, pp. 1345 - 1356
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 1, pp. 23 - 34
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 8, pp. 722 - 730
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 384, Issue 9948, pp. 1109 - 1117
Journal Article
Journal Article
Pharmacogenomics and personalized medicine, ISSN 1178-7066, 11/2014, Volume 7, pp. 357 - 365
T-lymphocytes have the potential to recognize cancer antigens as foreign and therefore eliminate them. However, immune checkpoints such as cytotoxic... 
Immune checkpoints | Cytotoxic T-lymphocyte antigen 4 | Programmed cell death protein-1 | Immunotherapy | Care and treatment | Cell death | Innovations | Genetic aspects | Health aspects | Cancer | Antigens | Dendritic cells | Cytokines | Melanoma | Homeostasis | Cytotoxicity | Vaccines | Metastasis | FDA approval | Cancer therapies | Skin cancer | Lymphocytes | Biomarkers | Ligands | Lymphomas | Immune system | Apoptosis
Journal Article
Nature (London), ISSN 0028-0836, 10/2015, Volume 526, Issue 7573, pp. 453 - 457
Activation of oncogenes by mechanisms other than genetic aberrations such as mutations, translocations, or amplifications is largely undefined. Here we report... 
GENE | CHROMATIN | MULTIDISCIPLINARY SCIENCES | FRAMEWORK | RECEPTOR | NEUROBLASTOMA | MUTATIONS | DNA-SEQUENCING DATA | IDENTIFICATION | SEQ | DISCOVERY | NIH 3T3 Cells | Cell Proliferation | Molecular Weight | Histones - chemistry | Humans | Receptor Protein-Tyrosine Kinases - biosynthesis | Molecular Sequence Data | RNA, Messenger - analysis | Isoenzymes - chemistry | RNA Polymerase II - metabolism | Anaplastic Lymphoma Kinase | Neoplasms - genetics | HEK293 Cells | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Lysine - metabolism | Transcription Initiation, Genetic | Gene Expression Regulation, Neoplastic - genetics | Oncogenes - genetics | Introns - genetics | Signal Transduction | Isoenzymes - genetics | RNA, Messenger - genetics | Neoplasms - enzymology | Protein Structure, Tertiary - genetics | Neoplasms - drug therapy | Animals | Receptor Protein-Tyrosine Kinases - genetics | Cell Transformation, Neoplastic | Alleles | Cell Line, Tumor | Mice | Histones - metabolism | Isoenzymes - biosynthesis | Methylation | Isoenzymes - antagonists & inhibitors | Receptor Protein-Tyrosine Kinases - chemistry | Development and progression | Genetic aspects | Genetic transcription | Health aspects | Oncogenes | Cancer | Proteins | Phosphorylation | Thyroid cancer | Genes | Melanoma | Tumorigenesis | Metastasis | Kinases | Cancer therapies | Binding sites | Tumors
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 5, pp. 986 - 997
Radiation therapy has long played a role in the management of melanoma. Recent advances have also demonstrated the efficacy of immunotherapy in the treatment... 
Radiology | Hematology, Oncology and Palliative Medicine | TUMOR-INFILTRATING LYMPHOCYTES | TOTAL-BODY IRRADIATION | METASTATIC MELANOMA | PHASE-II TRIAL | UVEAL MELANOMA | ONCOLOGY | BRAIN METASTASES | CHOROIDAL MELANOMA | MALIGNANT-MELANOMA | INTERFERON-BETA |